Point72 Asset Management
VRCA icon

Point72 Asset Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Point72 Asset Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-337
Closed -$21.9K – 2935
2023
Q1 		$21.9K Buy
+337
New +$20.4K ﹤0.01% 1956
2022
Q4 		– Sell
-48,580
Closed -$1.42M – 1923
2022
Q3 		$1.42M Sell
48,580
-26,815
-36% -$919K 0.01% 1001
2022
Q2 		$1.45M Buy
+75,395
New +$3.79M 0.01% 1008
2019
Q3 		– Sell
-14,221
Closed -$1.65M – 1515
2019
Q2 		$1.65M Sell
14,221
-506
-3% -$47.5K 0.01% 683
2019
Q1 		$1.59M Buy
14,727
+1,722
+13% +$199K 0.01% 736
2018
Q4 		$1.06M Buy
13,005
+4,005
+45% +$486K 0.01% 802
2018
Q3 		$1.46M Buy
+9,000
New +$1.54M 0.01% 802

Other funds holding VRCA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return